Entrevistas con especialistas de la EADV

Vea algunos de los expertos internacionales que colaboraron en el 30º congreso de la EADV.

 
Emerging priorities for microbiome research
 
15
What is the most important advance in our understanding of how microbes interact with humans?
75
How does the microbiome influence health?
163
How can this information be used to develop new treatment options for skin diseases?
287
What current research do you think will deliver the next generation of treatments?
 
 
The role of senescence in health and disease
 
15
What is senescence?
75
What role does it play in normal biology?
159
How does senescence affect fibrotic diseases?
259
Are there any therapies that address senescence in disease?

 

 
Autoinflammation and autoimmunity: New concepts
 
14
What advances have been made in the understanding of autoinflammation and autoimmunity in recent years?
61
How does this change our understanding of inflammatory autoimmune disease?
106
Can these new concepts help deliver new treatments?
166
What do you expect we will see in the future?

 

 
Atopic dermatitis and biologics after 5 years: Where are we?
 
14
Traditionally, what options have there been for atopic dermatitis? How has this changed?
293
What has driven this revolution in the field?
485
What new therapies are in development?
686
What does the future hold in the treatment of AD?

 

 
The power of touch
 
14
What biological processes are involved in our sense of touch?
88
How does touch affect human interactions?
133
How can the sense of touch be affected by disease?
219
How can dermatologists increase their awareness of the importance of touch?
269
Does physical touch reduce stress?

 

 
Identification and functional characterization of phenotype modifying genetic variants in CYLD cutaneous syndrome
 
14
What is CYLD cutaneous syndrome, and how common is it?
86
How have genotype-phenotype studies helped advance knowledge?
220
What treatments are available, and how do you expect this to change in the future?

 

 
COVID-19 and vaccination in Europe: Where are we now?
 
14
What is mRNA and how do mRNA vaccines work?
94
What made it possible to develop the COVID-19 vaccines so quickly?
215
Can mRNA vaccines be used in people with autoimmune or inflammatory conditions?
266
What do you predict for the coming months?

 

 
Clinical phenotypes of chronic prurigo
 
14
What is the definition of chronic prurigo?
83
What are the different clinical manifestations?
135
What are the core symptoms?
163
Are there different possible underlying causes of prurigo?
238
How is the burn of the disease?

Acerca de la EADV Comentario Biblioteca de audio